These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

418 related articles for article (PubMed ID: 10851253)

  • 1. Circadian rhythm abnormalities of melatonin in Smith-Magenis syndrome.
    Potocki L; Glaze D; Tan DX; Park SS; Kashork CD; Shaffer LG; Reiter RJ; Lupski JR
    J Med Genet; 2000 Jun; 37(6):428-33. PubMed ID: 10851253
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Inverted rhythm of melatonin secretion in Smith-Magenis syndrome: from symptoms to treatment.
    De Leersnyder H
    Trends Endocrinol Metab; 2006 Sep; 17(7):291-8. PubMed ID: 16890450
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Inversion of the circadian melatonin rhythm in Smith-Magenis syndrome].
    De Leersnyder H; de Blois MC; Bresson JL; Sidi D; Claustrat B; Munnich A
    Rev Neurol (Paris); 2003 Nov; 159(11 Suppl):6S21-6. PubMed ID: 14646795
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Review of disrupted sleep patterns in Smith-Magenis syndrome and normal melatonin secretion in a patient with an atypical interstitial 17p11.2 deletion.
    Boudreau EA; Johnson KP; Jackman AR; Blancato J; Huizing M; Bendavid C; Jones M; Chandrasekharappa SC; Lewy AJ; Smith AC; Magenis RE
    Am J Med Genet A; 2009 Jul; 149A(7):1382-91. PubMed ID: 19530184
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Inversion of the circadian rhythm of melatonin in the Smith-Magenis syndrome.
    De Leersnyder H; De Blois MC; Claustrat B; Romana S; Albrecht U; Von Kleist-Retzow JC; Delobel B; Viot G; Lyonnet S; Vekemans M; Munnich A
    J Pediatr; 2001 Jul; 139(1):111-6. PubMed ID: 11445803
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Twenty-four-hour motor activity and body temperature patterns suggest altered central circadian timekeeping in Smith-Magenis syndrome, a neurodevelopmental disorder.
    Smith ACM; Morse RS; Introne W; Duncan WC
    Am J Med Genet A; 2019 Feb; 179(2):224-236. PubMed ID: 30690916
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Circadian rhythm disorder in a rare disease: Smith-Magenis syndrome.
    De Leersnyder H; Claustrat B; Munnich A; Verloes A
    Mol Cell Endocrinol; 2006 Jun; 252(1-2):88-91. PubMed ID: 16723183
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Smith-Magenis syndrome.
    De Leersnyder H
    Handb Clin Neurol; 2013; 111():295-6. PubMed ID: 23622179
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Neurologic and developmental features of the Smith-Magenis syndrome (del 17p11.2).
    Gropman AL; Duncan WC; Smith AC
    Pediatr Neurol; 2006 May; 34(5):337-50. PubMed ID: 16647992
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Variability in clinical phenotype despite common chromosomal deletion in Smith-Magenis syndrome [del(17)(p11.2p11.2)].
    Potocki L; Shaw CJ; Stankiewicz P; Lupski JR
    Genet Med; 2003; 5(6):430-4. PubMed ID: 14614393
    [TBL] [Abstract][Full Text] [Related]  

  • 11. beta(1)-adrenergic antagonists improve sleep and behavioural disturbances in a circadian disorder, Smith-Magenis syndrome.
    De Leersnyder H; de Blois MC; Vekemans M; Sidi D; Villain E; Kindermans C; Munnich A
    J Med Genet; 2001 Sep; 38(9):586-90. PubMed ID: 11546826
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Sleep Complaints and the 24-h Melatonin Level in Individuals with Smith-Magenis Syndrome: Assessment for Effective Intervention.
    Spruyt K; Braam W; Smits M; Curfs LM
    CNS Neurosci Ther; 2016 Nov; 22(11):928-935. PubMed ID: 27743421
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Point and interval estimations of circadian melatonin ecphasia in Smith-Magenis syndrome.
    Cornélissen G; Halberg F; Tarquini R; Perfetto F; Salti R; Laffi G; Otsuka K
    Biomed Pharmacother; 2003 Oct; 57 Suppl 1():31s-34s. PubMed ID: 14572674
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Diagnostic FISH probes for del(17)(p11.2p11.2) associated with Smith-Magenis syndrome should contain the RAI1 gene.
    Vlangos CN; Wilson M; Blancato J; Smith AC; Elsea SH
    Am J Med Genet A; 2005 Jan; 132A(3):278-82. PubMed ID: 15690371
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Smith-Magenis syndrome: report of one case.
    Hou JW
    Acta Paediatr Taiwan; 2003; 44(3):161-4. PubMed ID: 14521023
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Hypoventilation in REM sleep in a case of 17p11.2 deletion (Smith-Magenis syndrome).
    Leoni C; Cesarini L; Dittoni S; Battaglia D; Novelli A; Bernardini L; Losurdo A; Vollono C; Testani E; Della Marca G; Zampino G
    Am J Med Genet A; 2010 Mar; 152A(3):708-12. PubMed ID: 20186811
    [TBL] [Abstract][Full Text] [Related]  

  • 17. New developments in Smith-Magenis syndrome (del 17p11.2).
    Gropman AL; Elsea S; Duncan WC; Smith AC
    Curr Opin Neurol; 2007 Apr; 20(2):125-34. PubMed ID: 17351481
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Smith-Magenis syndrome and growth hormone deficiency.
    Spadoni E; Colapietro P; Bozzola M; Marseglia GL; Repossi L; Danesino C; Larizza L; Maraschio P
    Eur J Pediatr; 2004 Jul; 163(7):353-8. PubMed ID: 15138811
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Cognitive and adaptive behavior profiles in Smith-Magenis syndrome.
    Madduri N; Peters SU; Voigt RG; Llorente AM; Lupski JR; Potocki L
    J Dev Behav Pediatr; 2006 Jun; 27(3):188-92. PubMed ID: 16775514
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Systemic growth hormone corrects sleep disturbance in Smith-Magenis syndrome.
    Itoh M; Hayashi M; Hasegawa T; Shimohira M; Kohyama J
    Brain Dev; 2004 Oct; 26(7):484-6. PubMed ID: 15351087
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 21.